Oak Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Oak Asset Management's BMY Position: Q3 2023 in Review
Oak Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,315 shares — an estimated $212K sold.
Oak Asset Management first reported a position in BMY in Q4 2017 and held it in 21 quarters. The position peaked at $2.17M in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Oak Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Oak Asset Management sold 3,315 Bristol-Myers Squibb shares in Q3 2023, an estimated $212K.
- Oak Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 21 quarters.
- Oak Asset Management's Bristol-Myers Squibb position peaked at $2.17M in Q4 2019.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Oak Asset Management's 13F filing for Q3 2023, filed 26 Oct 2023.